Tesla stock will try to make it three rises in a row, clawing back some of its recent losses. Whatever happens to close out ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at generic pharmaceuticals stocks, starting ...